These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1445326)

  • 1. A 16 amino acid synthetic peptide derived from human C3d triggers proliferation and specific tyrosine phosphorylation of transformed CR2-positive human lymphocytes and of normal resting B lymphocytes.
    Frade R; Hermann J; Barel M
    Biochem Biophys Res Commun; 1992 Oct; 188(2):833-42. PubMed ID: 1445326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 16 amino-acid synthetic peptide, derived from human C3d, carries regulatory activity on in vitro phosphorylation of a cellular component of the human B lymphoma cells, Raji.
    Lyamani F; Gauffre A; Barel M; Fiandino-Tirel A; Hermann J; Frade R
    Biochem Biophys Res Commun; 1991 Mar; 175(3):823-30. PubMed ID: 2025256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus/C3d receptor (CR2, CD21) activated by its extracellular ligands regulates pp105 phosphorylation through two distinct pathways.
    Bouillie S; Barel M; Drane P; Cassinat B; Balbo M; Holers VM; Frade R
    Eur J Immunol; 1995 Sep; 25(9):2661-7. PubMed ID: 7589142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor.
    Pernegger G; Schulz TF; Hosp M; Myones BL; Petzer AL; Eigentler A; Böck G; Wick G; Dierich MP
    Immunology; 1988 Oct; 65(2):237-41. PubMed ID: 2461345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pep34, a synthetic peptide whose sequence corresponds to the intracytoplasmic domain of the Epstein-Barr virus receptor (CR2, CD21), regulates human B lymphocyte proliferation triggered through CR2.
    Balbo M; Barel M; Bouillie S; Drane P; Cassinat B; Frade R
    Mol Immunol; 1995 Nov; 32(16):1295-8. PubMed ID: 8559153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3 synthetic peptides support growth of human CR2-positive lymphoblastoid B cells.
    Servis C; Lambris JD
    J Immunol; 1989 Apr; 142(7):2207-12. PubMed ID: 2784456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.
    Lambris JD; Ganu VS; Hirani S; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4235-9. PubMed ID: 2408276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.
    Bouillie S; Barel M; Frade R
    J Immunol; 1999 Jan; 162(1):136-43. PubMed ID: 9886379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular interaction of EBV/C3d receptor (CR2) with p68, a calcium-binding protein present in normal but not in transformed B lymphocytes.
    Barel M; Gauffre A; Lyamani F; Fiandino A; Hermann J; Frade R
    J Immunol; 1991 Aug; 147(4):1286-91. PubMed ID: 1831222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the EBV/C3d receptor (CR2, CD21) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95-kDa nucleolin and its interaction with phosphatidylinositol 3 kinase.
    Barel M; Le Romancer M; Frade R
    J Immunol; 2001 Mar; 166(5):3167-73. PubMed ID: 11207269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity.
    Toapanta FR; Ross TM
    Immunol Res; 2006; 36(1-3):197-210. PubMed ID: 17337780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21).
    Esparza I; Becherer JD; Alsenz J; De la Hera A; Lao Z; Tsoukas CD; Lambris JD
    Eur J Immunol; 1991 Nov; 21(11):2829-38. PubMed ID: 1834472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. gp 140, the C3d/EBV receptor (CR2), is phosphorylated upon in vitro activation of human peripheral B lymphocytes.
    Barel M; Vazquez A; Charriaut C; Aufredou MT; Galanaud P; Frade R
    FEBS Lett; 1986 Mar; 197(1-2):353-6. PubMed ID: 2936622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
    Weis JJ; Tedder TF; Fearon DT
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):881-5. PubMed ID: 6230668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
    Weis JJ; Fearon DT; Klickstein LB; Wong WW; Richards SA; de Bruyn Kops A; Smith JA; Weis JH
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5639-43. PubMed ID: 3016712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3d-mediated negative and positive signals on the proliferation of human B cells separated from blood.
    Kuraya M; Nilsson B; Nilsson-Ekdahl K; Klein E
    Immunol Lett; 1990 Oct; 26(1):51-8. PubMed ID: 2177450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.
    Weis JJ; Toothaker LE; Smith JA; Weis JH; Fearon DT
    J Exp Med; 1988 Mar; 167(3):1047-66. PubMed ID: 2832506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.
    Hatzfeld A; Fischer E; Levesque JP; Perrin R; Hatzfeld J; Kazatchkine MD
    J Immunol; 1988 Jan; 140(1):170-5. PubMed ID: 2826586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell activation induced by cross-linking CD3 and CD28 leads to silencing of Epstein-Barr virus/C3d receptor (CR2/CD21) gene and protein expression.
    Masilamani M; von Seydlitz E; Bastmeyer M; Illges H
    Immunobiology; 2002 Dec; 206(5):528-36. PubMed ID: 12607728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.